Edition:
India

Cadila Healthcare Gets Warning Letter Issued By US FDA Relating To Moraiya Formulation Facility


Monday, 4 Nov 2019 

Nov 4 (Reuters) - Cadila Healthcare Ltd ::. - WARNING LETTER - US FDA.SAYS COMPANY HAS RECEIVED A WARNING LETTER ISSUED BY US FDA RELATING TO ITS MORAIYA FORMULATION FACILITY..WARNING LETTER RELATING TO ITS MORAIYA FORMULATION FACILITY.WILL CONTINUE TO TAKE NECESSARY STEPS TO ENSURE THAT US FDA IS FULLY SATISFIED WITH REMEDIATION OF ABOVE FACILITY.CONFIDENT OF RESPONDING TO US FDA TO ADDRESS THE OBSERVATIONS WITHIN THE STATUTORY TIME.CADILA HEALTHCARE -WARNING LETTER DOES NOT AFFECT EXISTING BUSINESS OF CO IN US AND THE EXISTING PRODUCT SUPPLIES FROM MORAIYA FACILITY TO CONTINUE.. 

Company Quote

255.3
-2.35 -0.91%
6 Dec 2019